Related Experiment Video
Updated: Aug 18, 2026

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
Published on: February 17, 2023
Podophyllotoxin derivatives: current synthetic approaches for new anticancer agents
1Department of Chemistry, University at Buffalo, The State University of New York, Buffalo, NY 14260-3000, USA. yjyou@eng.buffalo.edu
Abstract:
Podophyllotoxin is an antimitotic natural product. Its inhibitory activity on cell growth led to the development of the clinically valuable anticancer agents, etoposide, teniposide and the water-soluble prodrug, etoposide phosphate. The cytotoxic mechanism of these drugs is the inhibition of topoisomerase II, unlike the lead compound which inhibits mitosis. Through extensive structure-activity relationship studies, several potential drug candidates were synthesized such as GL-331, TOP 53, NK611, and azatoxin. Recently, more complex and diverse analogues have been synthesized either to get more potent compounds or to overcome drug resistance. At the same time, a number of prodrug approaches have been tried to enhance the tumor selectivity or to increase the aqueous solubility. The prodrugs can release cytotoxic etoposide through the actions of hydrolysis, enzymes or catalytic antibodies. More sophisticated prodrug strategies have been applied in etoposide and these produced some interesting results. In this review, the current research trends in the design of new derivatives will be covered with a brief introduction of podophyllotoxin and related analogues.
Insights
Podophyllotoxin derivatives are explored for cancer treatment. New analogues and prodrugs aim for enhanced potency, tumor selectivity, and overcoming drug resistance, building on etoposide
Area of Science:
- Natural Products Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Podophyllotoxin is a natural product with antimitotic properties.
- It served as the basis for clinically used anticancer drugs like etoposide and teniposide.
- These drugs function by inhibiting topoisomerase II, distinct from podophyllotoxin's mechanism.
Purpose of the Study:
- To review current research trends in designing new podophyllotoxin derivatives.
- To explore strategies for enhancing anticancer drug potency and overcoming resistance.
- To discuss prodrug approaches for improved tumor selectivity and solubility.
Main Methods:
- Structure-activity relationship studies to synthesize novel analogues.
- Development of prodrug strategies for etoposide and related compounds.
- Synthesis of diverse and complex podophyllotoxin derivatives.
Main Results:
- Several potential drug candidates (e.g., GL-331, TOP 53) have been synthesized.
- Newer analogues aim for increased potency and resistance circumvention.
- Prodrug approaches show promise in enhancing tumor selectivity and solubility.
Conclusions:
- Continued research into podophyllotoxin derivatives and prodrugs is crucial for developing more effective cancer therapies.
- Novel synthetic strategies are yielding promising anticancer agents.
- Prodrug modifications offer a viable route to improve the therapeutic index of existing drugs.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Pharmaceutical Poisoning: Treatment Strategies
Drugs that Destabilize Microtubules
Antifungal Agents
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
